Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and bra...
Abbott Laboratories (ABT) has a valuation score of 82/100 (strong), profitability score of 64/100 (moderate), financial health score of 67/100 (moderate), Piotroski F-Score of 7/9, Altman Z-Score of 2.87 (grey zone), revenue growth of +0.5% YoY.
Neutral
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Aug 31, 2026
Analyst Recommendations33 analysts · 2026-08-01
11
13
9
Strong Buy 11Buy 13Hold 9Sell 0Strong Sell 0
Earnings
View earnings calendar →Recent Earnings Results
| Date | Time | EPS Est. | EPS Actual | Surprise | Rev Est. | Rev Actual |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | After-Hrs | — | — | — | — | — |
Recent Market Moves
See all ABT moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 27 | Regular | $111.57 | -2.22% | -2.24 |
| Aug 27 | After-hours | $111.60 | -2.19% | -2.22 |